The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets
Expert Review of Pharmacoeconomics & Outcomes Research · 21.04.2025 · 25 (4) · 487-506
DOI: 10.1080/14737167.2025.2451732 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, online erschienen am 15.01.2025. Verfasst von Julia M L Brotherton und 2 weiteren Autor:innen. Beteiligte Einrichtung: Evaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Vict…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Vaccines. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 180 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Cervical cancer is almost entirely preventable by vaccination and screening. Population-based vaccination and screening programs are effective and cost effective, but millions of people do not have access to these programs, causing immense suffering. The WHO Global Strategy for the elimination of cervical cancer as a public health problem calls for countries to meet ambitious vaccination, screening, and treatment targets. AREAS COVERED: Epidemiological evidence indicates marked socioeconomic gradients in the burden of cervical cancer and vaccination, screening, and treatment coverage. The unacceptable socioeconomic burden of cervical cancer is largely a function of inequitable access to these programs. We discuss these inequities, and highlight strategies enabled by new evidence and technology. Single dose HPV vaccination, HPV-based screening, and the rapidly moving technology landscape have enabled task-shifting, innovation in service delivery and the possibility of scale. Equitable access to optimal care for the treatment of invasive cancers remains a challenge. EXPERT OPINION: Cervical cancer can be eliminated equitably. It will require global political will, sustained public and private investment, and community leadership to safely and sustainably embed proven tools, technology and infrastructure in local health and knowledge systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia.
- National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia.
- Surveillance and Evaluation Research Program, Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Zitieren
APA
Brotherton, J. M. L., Vajdic, C. M., & Nightingale, C. (2025). The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets. Expert Review of Pharmacoeconomics & Outcomes Research, 25(4), 487-506. https://doi.org/10.1080/14737167.2025.2451732
Vancouver
Brotherton JML, Vajdic CM, Nightingale C. The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets. Expert Review of Pharmacoeconomics & Outcomes Research. 2025;25(4):487-506. doi:10.1080/14737167.2025.2451732
BibTeX
@article{Brotherton2025,
author = {Brotherton, Julia M L and Vajdic, Claire M and Nightingale, Claire},
title = {The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2025},
volume = {25},
number = {4},
pages = {487--506},
doi = {10.1080/14737167.2025.2451732}
}
EUVIMED